A major healthcare provider recently announced that it would begin requiring preauthorization for prescriptions of the buprenorphine-based addiction medications Suboxone and Subutex, a move that has raised concern among physicians and patient-advocacy groups about erecting new barriers to treatment. (Source: Alcohol, Tobacco and Other Drugs News)

Please take a moment to comment, write a post,or subscribe to our RSS feed!